Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yiping Fan

Showing results (131-140 of 148) with videos related to

Pageof 15
Sort By:
Nature Immunology|April 2, 2020
Beta cell-specific CD8<sup>+</sup> T cells maintain stem cell memory-associated epigenetic programs during type 1 diabetesHossam A Abdelsamed, Caitlin C Zebley, Hai Nguyen, et al.
Nature Communications|July 6, 2023
Genome-wide mapping of cancer dependency genes and genetic modifiers of chemotherapy in high-risk hepatoblastomaJie Fang, Shivendra Singh, Changde Cheng, et al.
Journal of the National Cancer Institute|March 21, 2013
Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populationsHeng Xu, Wenjian Yang, Virginia Perez-Andreu, et al.
Clinical and Translational Science|March 20, 2021
Identification of small molecules that mitigate vincristine-induced neurotoxicity while sensitizing leukemia cells to vincristineBarthelemy Diouf, Claudia Wing, John C Panetta, et al.
Cancer Discovery|February 23, 2020
Relapse-Fated Latent Diagnosis Subclones in Acute B Lineage Leukemia Are Drug Tolerant and Possess Distinct Metabolic ProgramsStephanie M Dobson, Laura García-Prat, Robert J Vanner, et al.
Blood|May 22, 2023
The genomic landscape of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21Qingsong Gao, Sarra L Ryan, Ilaria Iacobucci, et al.
Nature Communications|February 16, 2020
MYCN amplification and ATRX mutations are incompatible in neuroblastomaMaged Zeineldin, Sara Federico, Xiang Chen, et al.
Cancer Cell|August 28, 2018
Identification of Therapeutic Targets in Rhabdomyosarcoma through Integrated Genomic, Epigenomic, and Proteomic AnalysesElizabeth Stewart, Justina McEvoy, Hong Wang, et al.
Nature Communications|February 13, 2023
Proteasome inhibition targets the KMT2A transcriptional complex in acute lymphoblastic leukemiaJennifer L Kamens, Stephanie Nance, Cary Koss, et al.
Science Translational Medicine|July 20, 2022
Targeting KDM4 for treating PAX3-FOXO1-driven alveolar rhabdomyosarcomaShivendra Singh, Ahmed Abu-Zaid, Hongjian Jin, et al.
Pageof 15

Showing results (131-140 of 148) with videos related to

Sort By:
Pageof 15
Nature Immunology|April 2, 2020
Beta cell-specific CD8<sup>+</sup> T cells maintain stem cell memory-associated epigenetic programs during type 1 diabetesHossam A Abdelsamed, Caitlin C Zebley, Hai Nguyen, et al.
Nature Communications|July 6, 2023
Genome-wide mapping of cancer dependency genes and genetic modifiers of chemotherapy in high-risk hepatoblastomaJie Fang, Shivendra Singh, Changde Cheng, et al.
Journal of the National Cancer Institute|March 21, 2013
Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populationsHeng Xu, Wenjian Yang, Virginia Perez-Andreu, et al.
Clinical and Translational Science|March 20, 2021
Identification of small molecules that mitigate vincristine-induced neurotoxicity while sensitizing leukemia cells to vincristineBarthelemy Diouf, Claudia Wing, John C Panetta, et al.
Cancer Discovery|February 23, 2020
Relapse-Fated Latent Diagnosis Subclones in Acute B Lineage Leukemia Are Drug Tolerant and Possess Distinct Metabolic ProgramsStephanie M Dobson, Laura García-Prat, Robert J Vanner, et al.
Blood|May 22, 2023
The genomic landscape of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21Qingsong Gao, Sarra L Ryan, Ilaria Iacobucci, et al.
Nature Communications|February 16, 2020
MYCN amplification and ATRX mutations are incompatible in neuroblastomaMaged Zeineldin, Sara Federico, Xiang Chen, et al.
Cancer Cell|August 28, 2018
Identification of Therapeutic Targets in Rhabdomyosarcoma through Integrated Genomic, Epigenomic, and Proteomic AnalysesElizabeth Stewart, Justina McEvoy, Hong Wang, et al.
Nature Communications|February 13, 2023
Proteasome inhibition targets the KMT2A transcriptional complex in acute lymphoblastic leukemiaJennifer L Kamens, Stephanie Nance, Cary Koss, et al.
Science Translational Medicine|July 20, 2022
Targeting KDM4 for treating PAX3-FOXO1-driven alveolar rhabdomyosarcomaShivendra Singh, Ahmed Abu-Zaid, Hongjian Jin, et al.
Pageof 15